{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:19:35Z","timestamp":1790687975076,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bmc.2021.116156","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T22:06:41Z","timestamp":1618956401000},"page":"116156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Detection of N,N-diacetyllactosamine (LacdiNAc) containing free prostate-specific antigen for early stage prostate cancer diagnostics and for identification of castration-resistant prostate cancer patients"],"prefix":"10.1016","volume":"39","author":[{"given":"Aniko","family":"Bertokova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-2687","authenticated-orcid":false,"given":"Tomas","family":"Bertok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Jane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Hires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"\u010eubjakov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-4567","authenticated-orcid":false,"given":"O\u013ega","family":"Novotn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-4034","authenticated-orcid":false,"given":"Vitazoslav","family":"Belan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Fillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0765-7262","authenticated-orcid":false,"given":"Jan","family":"Tkac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2018","key":"10.1016\/j.bmc.2021.116156_b0005","first-page":"394","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2021.116156_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of Prostate Cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.bmc.2021.116156_b0015","article-title":"Racial\/ethnic variation in PSA testing and prostate cancer incidence following the 2012 U.S.P.S.T.F. recommendation","author":"Kensler","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.bmc.2021.116156_b0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10900-020-00923-8","article-title":"Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey","volume":"46","author":"Johnson","year":"2021","journal-title":"J Community Health"},{"issue":"2","key":"10.1016\/j.bmc.2021.116156_b0025","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2018.0077","article-title":"Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer","volume":"9","author":"Tkac","year":"2019","journal-title":"Interface Focus."},{"issue":"507","key":"10.1016\/j.bmc.2021.116156_b0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1984","article-title":"Applications of liquid biopsies for cancer","volume":"11","author":"Mattox","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.bmc.2021.116156_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/14789450.2019.1549993","article-title":"Glycomics of prostate cancer: updates","volume":"16","author":"Tkac","year":"2019","journal-title":"Expert Review of Proteomics"},{"key":"10.1016\/j.bmc.2021.116156_b0040","doi-asserted-by":"crossref","first-page":"18974","DOI":"10.1038\/s41598-020-75526-3","article-title":"Characterisation of the main PSA glycoforms in aggressive prostate cancer","volume":"10","author":"Gratac\u00f3s-Mulleras","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2021.116156_b0045","doi-asserted-by":"crossref","unstructured":"E.H. Kim, G.L. Andriole, Prostate-specific antigen-based screening: controversy and guidelines, BMC Med., 13 (2015) 61-61.","DOI":"10.1186\/s12916-015-0296-5"},{"key":"10.1016\/j.bmc.2021.116156_b0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/14737159.2014.928207","article-title":"Predictions for the future of kallikrein-related peptidases in molecular diagnostics","volume":"14","author":"Scorilas","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.bmc.2021.116156_b0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.urolonc.2018.11.021","article-title":"Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore","volume":"37","author":"Verbeek","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.bmc.2021.116156_b0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41391-017-0008-7","article-title":"Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting","volume":"21","author":"White","year":"2018","journal-title":"Prostate Cancer Prostatic Diseases"},{"key":"10.1016\/j.bmc.2021.116156_b0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1515\/hsz-2014-0140","article-title":"Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity","volume":"395","author":"Shihui","year":"2014","journal-title":"Biol Chem"},{"key":"10.1016\/j.bmc.2021.116156_b0070","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1021\/acs.jproteome.5b00362","article-title":"Characterization of the Glycosylation Site of Human PSA Prompted by Missense Mutation using LC\u2013MS\/MS","volume":"14","author":"Song","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.bmc.2021.116156_b0075","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/s41598-020-59622-y","article-title":"Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection","volume":"10","author":"Ideo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2021.116156_b0080","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1042\/BCJ20170853","article-title":"The sugar code: letters and vocabulary, writers, editors and readers and biosignificance of functional glycan-lectin pairing","volume":"476","author":"Kaltner","year":"2019","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2021.116156_b0085","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/ijms20061389","article-title":"Glycans as Biomarkers in Prostate Cancer","volume":"20","author":"Scott","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2021.116156_b0090","doi-asserted-by":"crossref","unstructured":"M. Jennifer, Glycosylation is a global target for androgen control in prostate cancer cells, Endocr.-Rel. Cancer, 24 (2017) R49-R64.","DOI":"10.1530\/ERC-16-0569"},{"key":"10.1016\/j.bmc.2021.116156_b0095","doi-asserted-by":"crossref","unstructured":"K. Hirano, A. Matsuda, T. Shirai, K. Furukawa, Expression of LacdiNAc groups on N-glycans among human tumors is complex, BioMed Res. Intern., 2014 (2014) 981627-981627.","DOI":"10.1155\/2014\/981627"},{"key":"10.1016\/j.bmc.2021.116156_b0100","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1021\/acs.analchem.8b04829","article-title":"Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA","volume":"91","author":"Haga","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmc.2021.116156_b0105","doi-asserted-by":"crossref","first-page":"24085","DOI":"10.1074\/jbc.M116.750463","article-title":"Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[\u03b21\u21924]GlcNAc), by Wisteria floribunda Agglutinin","volume":"291","author":"Haji-Ghassemi","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2021.116156_b0110","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/glycob\/cwx038","article-title":"Engineering of recombinant Wisteria floribunda agglutinin specifically binding to GalNAc\u03b21,4GlcNAc","volume":"27","author":"Sato","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.bmc.2021.116156_b0115","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1038\/s41598-020-62631-6","article-title":"Prognostic Role of Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Level in Early Stage Hepatocellular Carcinoma","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2021.116156_b0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/14789450.2018.1419066","article-title":"Wisteria floribunda agglutinin positive glycobiomarkers: a unique lectin as a serum biomarker probe in various diseases","volume":"15","author":"Narimatsu","year":"2018","journal-title":"Exp Rev Proteomics"},{"key":"10.1016\/j.bmc.2021.116156_b0125","doi-asserted-by":"crossref","unstructured":"B. Adamczyk, C. Jin, K. Polom, P. Mu\u00f1oz, M.A. Rojas- Macias, D. Zeeberg, M. Bor\u00e9n, F. Roviello, N.G. Karlsson, Sample handling of gastric tissue and O-glycan alterations in paired gastric cancer and non-tumorigenic tissues, Sci. Rep., 8 (2018) 242.","DOI":"10.1038\/s41598-017-18299-6"},{"key":"10.1016\/j.bmc.2021.116156_b0130","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1021\/ac503735e","volume":"87","author":"Kaya","year":"2015","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmc.2021.116156_b0135","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/cas.14082","article-title":"Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection","volume":"110","author":"Yoneyama","year":"2019","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.bmc.2021.116156_b0140","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.clgc.2019.10.011","article-title":"LacdiNAc-Glycosylated Prostate-specific Antigen Density is a Potential Biomarker of Prostate Cancer","volume":"18","author":"Inoue","year":"2020","journal-title":"Clinical Genitourinary Cancer"},{"key":"10.1016\/j.bmc.2021.116156_b0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ijms18020261","article-title":"Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer","volume":"18","author":"Hagiwara","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2021.116156_b0150","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.3390\/cancers12102988","article-title":"Validating fPSA glycoprofile as a prostate cancer biomarker to avoid unnecessary biopsies and re-biopsies","volume":"12","author":"Bertok","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2021.116156_b0155","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s42003-020-01363-9","article-title":"Aglycosylated antibody-producing mice for aglycosylated antibody-lectin coupled immunoassay for the quantification of tumor markers (ALIQUAT)","volume":"3","author":"Lee","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bmc.2021.116156_b0160","unstructured":"R.C. Team, R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. http s, www. R-proje ct. org, (2017)."},{"key":"10.1016\/j.bmc.2021.116156_b0165","unstructured":"M. Kuhn, J. Wing, S. Weston, A. Williams, C. Keefer, A. Engelhardt, T. Cooper, Z. Mayer, B. Kenkel, R.C. Team, Package \u2018caret\u2019, The R Journal, ftp:\/\/mirrors.ucr.ac.cr\/CRAN\/web\/packages\/caret\/caret.pdf (2020)."},{"key":"10.1016\/j.bmc.2021.116156_b0170","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","article-title":"Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians","volume":"19","author":"Carpenter","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.bmc.2021.116156_b0175","doi-asserted-by":"crossref","unstructured":"L. Scrucca, GA: a package for genetic algorithms in R. Journal of Statistical Software, Foundation for Open Access Statistics, 53 (2013).","DOI":"10.18637\/jss.v053.i04"},{"key":"10.1016\/j.bmc.2021.116156_b0180","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1590\/s1677-5538.ibju.2018.0768","article-title":"Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions","volume":"45","author":"Westphalen","year":"2019","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.bmc.2021.116156_b0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.11613\/BM.2015.045","article-title":"Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis","volume":"25","author":"Vermassen","year":"2015","journal-title":"Biochemia Medica"},{"key":"10.1016\/j.bmc.2021.116156_b0190","doi-asserted-by":"crossref","first-page":"16761","DOI":"10.1038\/s41598-019-53384-y","article-title":"Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer","volume":"9","author":"Matsumoto","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2021.116156_b0195","article-title":"New Non-Metastatic, Castration-Resistant Prostate Cancer Treatment","volume":"40","author":"Updates","year":"2018","journal-title":"Oncology Times"},{"key":"10.1016\/j.bmc.2021.116156_b0200","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41391-020-00271-7","article-title":"Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center","volume":"24","author":"McKay","year":"2021","journal-title":"Prostate Cancer Prost Dis"},{"key":"10.1016\/j.bmc.2021.116156_b0205","first-page":"6063","article-title":"Molecular and cellular mechanisms of castration resistant prostate cancer","volume":"15","author":"Huang","year":"2018","journal-title":"Oncology Letters"},{"key":"10.1016\/j.bmc.2021.116156_b0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ncpuro1296","article-title":"Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion","volume":"6","author":"Harris","year":"2009","journal-title":"Nature Clinical Practice Urology"},{"key":"10.1016\/j.bmc.2021.116156_b0215","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/1078-0432.CCR-04-0913","article-title":"The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer","volume":"10","author":"Nishiyama","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2021.116156_b0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5534\/wjmh.180040","article-title":"Role of androgen receptor in prostate cancer: a review","volume":"37","author":"Fujita","year":"2019","journal-title":"World J Men's Health"},{"key":"10.1016\/j.bmc.2021.116156_b0225","first-page":"133","article-title":"Effect of dutasteride on castration-resistant prostate cancer","volume":"8","author":"Azuma","year":"2018","journal-title":"Molecular Clinical Oncology"},{"key":"10.1016\/j.bmc.2021.116156_b0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jamaophthalmol.2017.0046","article-title":"Association of steroid 5\u03b1-reductase type 3 congenital disorder of glycosylation with early-onset retinal dystrophy","volume":"135","author":"Taylor","year":"2017","journal-title":"JAMA Ophthalmology"},{"key":"10.1016\/j.bmc.2021.116156_b0235","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s41431-020-0647-3","article-title":"SRD5A3 defective congenital disorder of glycosylation: clinical utility gene card","volume":"28","author":"Jaeken","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.bmc.2021.116156_b0240","unstructured":"SRD5A3 steroid 5 alpha-reductase 3 [Homo sapiens (human)], https:\/\/www.ncbi.nlm.nih.gov\/gene\/79644, 2020, pp. c."},{"key":"10.1016\/j.bmc.2021.116156_b0245","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.1096\/fj.201800687","article-title":"O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer","volume":"32","author":"Tzeng","year":"2018","journal-title":"FASEB J"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621001644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621001644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:12:37Z","timestamp":1760836357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621001644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":49,"alternative-id":["S0968089621001644"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116156","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of N,N-diacetyllactosamine (LacdiNAc) containing free prostate-specific antigen for early stage prostate cancer diagnostics and for identification of castration-resistant prostate cancer patients","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116156"}}